This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Myocardial infarction (MI) and fitness to fly

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Condition

Functional status

Lay explanation

Restriction/guidance

Post STEMI and NSTEMI

Low risk

Age <65, first event, successful reperfusion, EF>45%,no complications,no planned investigations or interventions

If you have had a heart attack but you are less than 65yrs, the blocked artery has been opened, the heart pump is not badly damaged and no further tests or treatment are planned

Fly after 3 days

Medium risk

EF >40%,no symptoms of heart failure,no evidence of inducible ischemia or arrhythmia,no planned investigations or interventions

If you have had a heart attack your heart pump is quite good and you have no symptoms of breathlessness or chest pain and no other tests or treatments are planned

Fly after 10 days

High risk

EF <40%,signs and symptoms of heart failure, those pending further investigation, revascularisation or device therapy

If you have had a heart attack, the heart pump is significantly damaged and you have symptoms of breathlessness or you are waiting for further tests or treatment

Defer travel until stable

Note that these are only guidelines and each airline has its own regulations and medical standards.

Reference:

  • British Heart Foundation (September 2010). Factfile - Fitness to fly for passengers with cardiovascular disease.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.